Family Medicine Doctors in Sturbridge, MA Accepting Medicare

5 Family Medicine doctors found. Showing 1 - 5

Dr. Gary F Jeznach, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 118 Main St, Sturbridge, MA 01566 Phone: 508-347-5755    Fax: 508-347-5702

Gennady Gelman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 198 Charlton Rd, Sturbridge, MA 01566 Phone: 508-347-9240    Fax: 508-347-5361

Mohamed Hashi Abib, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 128 Main St Ste 4, Sturbridge, MA 01566 Phone: 508-347-9240    Fax: 508-347-5361

Dr. Stephanie Elizabeth Keaney, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 67 Hall Rd, Suite 3, Sturbridge, MA 01566 Phone: 508-347-3344    Fax: 508-347-7319

Dr. Junjie Fang, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Main St, Suite 3, Sturbridge, MA 01566 Phone: 774-241-0450    Fax: 774-241-0583

News Archive

Study evaluates link between genetic and environmental factors and risk of drug abuse

In a national Swedish adoption study, the risk for drug abuse appears to be increased among adopted children whose biological parents had a history of drug abuse, according to a report published Online First by Archives of General Psychiatry, one of the JAMA/Archives journals.

Research reveals novel way to treat cancers using CAR T cell therapy

Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated researchers at Huntsman Cancer Institute at the University of Utah to try to improve the depth and durability of treatment response in multiple myeloma through a new cancer cell targeting mechanism.

FDA grants LFB's recombinant anti-CD20 monoclonal antibody orphan drug status for CLL

The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the FDA Office of Orphan Products Development was granted on August 6th, 2010.

Study: Investigational drug effective in reducing mucormycosis infections

With very few treatment options available to fight deadly mucormycosis infections, a new Los Angeles Biomedical Research Institute (LA BioMed) study holds hope for adding to the arsenal of therapies physicians have to combat an increasingly common infection afflicting people with weakened immune systems.

Read more Medical News

› Verified 5 days ago